EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Mega Genomics's Enterprise Value is HK$1,117.7 Mil.
Mega Genomics's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$95.3 Mil. Therefore, Mega Genomics's EV-to-FCF for today is 11.73.
The historical rank and industry rank for Mega Genomics's EV-to-FCF or its related term are showing as below:
HKSE:06667'
s EV-to-FCF Range Over the Past 10 Years
Min: -157.18 Med: 8.28 Max: 62.87
Current: 11.73
During the past 5 years, the highest EV-to-FCF of Mega Genomics was 62.87. The lowest was -157.18. And the median was 8.28.
HKSE:06667's EV-to-FCF is ranked better than 72.9% of 107
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.67
vs HKSE:06667: 11.73
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for Mega Genomics's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mega Genomics's EV-to-FCF
For the Diagnostics & Research subindustry, Mega Genomics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mega Genomics's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Mega Genomics's EV-to-FCF falls into.
Mega Genomics's current Enterprise Value is HK$1,117.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mega Genomics's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$95.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mega Genomics (HKSE:06667) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Mega Genomics's PE Ratio (TTM) for today is calculated as:
Mega Genomics's share price for today is HK$7.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mega Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.172.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Mega Genomics EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Mega Genomics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening, and infectious disease diagnosis, to meet consumers growing preventive medical needs. It generates a majority of its revenue from consumer genetic testing services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06667 has been successfully added to your 